Juan Frias
Net worth: - $ as of 29/06/2026
Net worth: - $ as of 29/06/2026
Juan Pablo Frias is currently Director at T1D Exchange.
Formerly, Dr. Frias was Chief Executive Officer at National Research Institute from 2013 to 2020.
Dr. Frias was President & Chief Executive Officer at NRI Clinical Research LLC.
Dr. Frias was Medical Director at Velocity Clinical Research, Inc. Dr. Frias was Chief Medical Officer & Head-Diabetes at Biomea Fusion, Inc. Dr. Frias was Chief Medical Officer at Johnson & Johnson from 2007 to 2010.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOMEA FUSION INC -.--% | 30/03/2026 | 0 ( -.--% ) | - $ | 29/06/2026 |
| Companies | Position | Start |
|---|---|---|
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
National Research Institute
National Research Institute BiotechnologyHealth Technology Provides innovative therapies for health care | Chief Executive Officer | 30/09/2020 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | 30/06/2010 |
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. Internet Software/ServicesTechnology Services Operates as a clinical research sites | Chief Tech/Sci/R&D Officer | - |
| BIOMEA FUSION, INC. | Chief Tech/Sci/R&D Officer | - |
NRI Clinical Research LLC
NRI Clinical Research LLC BiotechnologyHealth Technology Owns and operates clinical research center | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
National Research Institute
National Research Institute BiotechnologyHealth Technology Provides innovative therapies for health care | Health Technology |
NRI Clinical Research LLC
NRI Clinical Research LLC BiotechnologyHealth Technology Owns and operates clinical research center | Health Technology |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Health Technology |
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. Internet Software/ServicesTechnology Services Operates as a clinical research sites | Technology Services |
Biomea Fusion, Inc.
Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions